PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-97

  1. 850 Posts.
    lightbulb Created with Sketch. 210
    Paul doesn't sound completely confident that a deal would provide enough capital (50-60m USD) to cover the phase 3 costs. It baffles me that we could be giving up 85% of the asset's revenue in the US for example, for anything less than a number in the 100s of millions.
    Last edited by Duke2: 26/07/24
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.